Logo image
Back
7.1 Current and Projected Utilization of Total Joint Replacements
Book chapter

7.1 Current and Projected Utilization of Total Joint Replacements

K.L. Ong, D. Baykal, E. Lau and S.M. Kurtz
Comprehensive Biomaterials II, pp 1-11
2017
DOI: https://doi.org/10.1016/B978-0-12-803581-8.09251-1

Abstract

Epidemiology Health economics Implant registry Medicare Procedure rates Revision surgery Total hip arthroplasty Total hip replacement Total knee arthroplasty Total knee replacement
Total joint arthroplasty (TJA) is one of the most clinically efficacious and cost-effective interventions in health care. The United States, which performs roughly 1 million partial and total joint replacement procedures annually, accounts for roughly 50% of the world’s TJA procedures. Despite the downturn in the global economy, procedure volumes still continue to grow, and new biomaterials and implant technologies are continually introduced into the marketplace. The comparative effectiveness of new technologies, the costs and appropriateness of new TJA procedures and related biomaterials continue to be the subject of increased public scrutiny and debate. Understanding the epidemiology of TJA is important for guiding research, implant design, clinical decision-making, and health care policy related to TJA, particular with increasing cost pressures. International total joint registries provide valuable information regarding the outcomes of total joint replacements in Europe and in other countries, such as Australia and New Zealand. Although the American Joint Replacement Registry (AJRR) was established in 2010, the United States still currently lack a national TJA registry. Thus, administrative databases still offer the only nationwide source of epidemiological data for orthopedic procedures. As such, administrative databases offer unique insights into the current and projected use of TJA across the entire US population.

Metrics

20 Record Views

Details

Logo image